Novo Nordisk launches weight-loss drug Wegovy in India to compete with rival Lilly’s Mounjaro
The market potential in India, a country of more than 1.4 billion people, is significant, with obesity and diabetes rates steadily climbing. Wegovy is …
The Heartbeat of World events
The market potential in India, a country of more than 1.4 billion people, is significant, with obesity and diabetes rates steadily climbing. Wegovy is …
